CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
15.02
+0.23 (1.56%)
Oct 9, 2025, 12:07 PM EDT - Market open
CareDx Revenue
CareDx had revenue of $86.68M in the quarter ending June 30, 2025, a decrease of -6.06%. This brings the company's revenue in the last twelve months to $340.83M, up 14.72% year-over-year. In the year 2024, CareDx had annual revenue of $333.79M with 19.07% growth.
Revenue (ttm)
$340.83M
Revenue Growth
+14.72%
P/S Ratio
2.35
Revenue / Employee
$524,348
Employees
650
Market Cap
799.47M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 333.79M | 53.46M | 19.07% |
Dec 31, 2023 | 280.32M | -41.47M | -12.89% |
Dec 31, 2022 | 321.79M | 25.40M | 8.57% |
Dec 31, 2021 | 296.40M | 104.20M | 54.22% |
Dec 31, 2020 | 192.19M | 65.13M | 51.25% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CDNA News
- 3 days ago - CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting - Business Wire
- 5 weeks ago - CareDx Issues Comment Letter on Draft LCD Policy - Business Wire
- 6 weeks ago - CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential - Benzinga
- 6 weeks ago - CareDx to Participate in Wells Fargo Healthcare Conference - Business Wire
- 2 months ago - CareDx, Inc (CDNA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - CareDx Announces Appointment of Nathan Smith as Chief Financial Officer - Business Wire
- 2 months ago - CareDx Announces Second Quarter 2025 Financial Results - Business Wire
- 2 months ago - CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation - Business Wire